Robin Vacha - Nov 15, 2023 Form 4 Insider Report for Azenta, Inc. (AZTA)

Role
SVP, GM Life Science Products
Signature
/s/Jason W. Joseph, Attorney-in-fact for Robin Vacha
Stock symbol
AZTA
Transactions as of
Nov 15, 2023
Transactions value $
$313,827
Form type
4
Date filed
11/17/2023, 04:12 PM
Previous filing
Aug 14, 2023
Next filing
Dec 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AZTA Common Stock Award $222K +4.11K +16.28% $54.13 29.3K Nov 15, 2023 Direct F1
transaction AZTA Common Stock Disposed to Issuer -$159K -2.95K -10.05% $53.81 26.4K Nov 16, 2023 Direct F2
transaction AZTA Common Stock Award $250K +4.58K +17.37% $54.57 31K Nov 16, 2023 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares issued upon the vesting of performance-based units granted on November 13, 2020, of which one-third was determined to be earned at 150% and converted into restricted stock units which vested on November 15, 2023. No amount was paid by the reporting person upon grant or vesting of the performance-based units.
F2 The sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2023 of 4,107 performance stock units and 2,755 of restricted stock units held by the reporting person.
F3 Grant of restricted stock units to the Reporting Person under the Company's Long Term Incentive Plan. No amount was paid upon grant of the units. The units are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 15, 2024.